This is, in truth, nearly the best of what US life science companies can offer, as corporate citizenship.
We face a global pandemic -- one that may well be soon arrested, if only we can produce enough vaccine stock to immunize the bulk of the population. But no one company can produce enough -- not even close. So, in resonance with President Biden's calling for more humane, soulful treatment of all of us. . . these two titans will. . . cooperate and in the process, geometrically speed the delivery of vaccines, around the globe. [And each will make profit on the deal.] Here's a bit, via the WaPo:
. . .President Biden will announce Tuesday that pharmaceutical giant Merck will help make Johnson & Johnson’s single-shot coronavirus vaccine — an unusual pact between fierce competitors that could sharply boost the supply of the newly authorized vaccine, according to senior administration officials.
The officials, who spoke on the condition of anonymity to discuss a matter that has not been announced, said they began scouring the country for additional manufacturing capacity after they realized in the first days of the administration that Johnson & Johnson had fallen behind in vaccine production. They soon sought to broker a deal with Merck, one of the world’s largest vaccine makers. . . .
Onward, smiling at all the good there is -- reawakening the "doing well, by doing. . . good" mantra -- in this now newly cooperative world.
नमस्ते
No comments:
Post a Comment